Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07816029) titled 'Append Prague Study' on Sept. 7.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Append Medical Ltd.

Condition: Non Valvular Atrial Fibrillation

Intervention: Device: Append System

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: July 16, 2025

Target Sample Size: 75

Countries of Recruitment: Czechia

To know more, visit https://clinicaltrials.gov/study/NCT07816029

Published by HT Digital Content Services with permission from Health Daily Digest....